Alivus Life Sciences Limited has informed the Exchange about Schedule of meet - Earnings Call.

Board & Shareholder Meetings View source PDF

ALIVUS · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close

+0.8%1-day move

₹1117.10

prior close

₹1125.90

base price

In-mkt

timing

5m10m15m30m1D2D3D4D5D7D15D1M2M3M

+0.1+0.2-0.1-0.1+0.8-1.2-2.7-4.6-7.3-4.9-6.2-10.6+1.6—

Up moveDown movePending

AI summary

Alivus Life Sciences Limited (formerly Glenmark Life Sciences Limited) has scheduled its Q4 and full year FY2025-26 earnings call for Friday, May 15, 2026, from 8:30 AM to 9:30 AM IST. The call will discuss the company's financial performance for the quarter and full fiscal year ended March 2026. Dial-in details and international access numbers are provided. EY representatives Diwakar Pingle and Runjhun Jain are the contact persons for investor queries.

Likely market impact

This is a routine regulatory intimation. The earnings call signals that Q4 and annual results are expected shortly. No price-sensitive information is disclosed at this stage.